Birkhead J S, Weston C F M, Chen R
National Institute for Clinical Outcomes Research, The Heart Hospital, London, UK.
Heart. 2009 Oct;95(19):1593-9. doi: 10.1136/hrt.2008.164426. Epub 2009 Jun 8.
To investigate determinants of, and outcomes from, coronary angiography and intervention in patients with non-ST-segment elevation myocardial infarction (NSTEMI).
Observational study.
44 British hospitals with interventional facilities.
13,489 admissions with NSTEMI; July 2005 to December 2006.
Rate of angiography during index admission; death and readmission to hospital within 180 days.
Significantly lower rates of angiography were seen for women, the elderly, the most deprived and those having cardiac, and most non-cardiac, comorbidities. Performance of angiography, compared with no angiography, was not associated with lower rate of readmission (multiple adjusted hazard ratio (HR) = 0.96, 95% CI 0.74 to 1.24) unless accompanied by coronary intervention (HR = 0.73, 95% CI 0.56 to 0.95). Angiography was associated with reduction in 180-day mortality for survivors of hospitalisation (HR = 0.59, 95% CI 0.49 to 0.72); with greater reduction when followed by an intervention (HR = 0.34, 95% CI 0.28 to 0.42). This mortality benefit after intervention was seen both in women (HR = 0.42, 95% CI 0.29 to 0.60) and men (HR = 0.31, 95% CI 0.24 to 0.41), and across age groups: <65 years (HR = 0.25, 95% CI 0.14 to 0.44), 65-79 years (HR = 0.29, 95% CI 0.22 to 0.39) and > or =80 years (HR = 0.52, 95% CI 0.37 to 0.74). Mortality benefit was not significantly attenuated by the presence of comorbidities.
Performance of angiography and coronary intervention after NSTEMI was associated with mortality benefit that persisted in the presence of both cardiac and non-cardiac comorbidities. Mortality benefit was seen across age groups and was similar for both sexes.
研究非ST段抬高型心肌梗死(NSTEMI)患者冠状动脉造影及干预的决定因素和结果。
观察性研究。
44家具备介入设施的英国医院。
2005年7月至2006年12月期间13489例NSTEMI住院患者。
首次住院期间的冠状动脉造影率;180天内的死亡率和再入院率。
女性、老年人、最贫困人群以及患有心脏和大多数非心脏合并症的患者,其冠状动脉造影率显著较低。与未进行冠状动脉造影相比,进行冠状动脉造影与再入院率降低无关(多因素调整风险比(HR)=0.96,95%置信区间0.74至1.24),除非同时进行冠状动脉干预(HR = 0.73,95%置信区间0.56至0.95)。冠状动脉造影与住院幸存者180天死亡率降低相关(HR = 0.59,95%置信区间0.49至0.72);若随后进行干预,死亡率降低幅度更大(HR = 0.34,95%置信区间0.28至0.42)。干预后的这种死亡率获益在女性(HR = 0.42,95%置信区间0.29至0.60)和男性(HR = 0.31,95%置信区间0.24至0.41)中均可见,且在各年龄组中均如此:<65岁(HR = 0.25,95%置信区间0.14至0.44)、65 - 79岁(HR = 0.29,95%置信区间0.22至0.39)以及≥80岁(HR = 0.52,95%置信区间0.37至0.74)。合并症的存在并未显著削弱死亡率获益。
NSTEMI后进行冠状动脉造影和冠状动脉干预与死亡率获益相关,在存在心脏和非心脏合并症的情况下该获益依然存在。各年龄组均可见死亡率获益,且男女相似。